This study identified a subtype enriched in advanced melanoma exhibiting a highly differentiated state and possesses immunoregulatory functions, which is predicted to simultaneously send dual signals via the MHC-II and PROS1 pathways, coordinating both the immune and neural microenvironments. This evidence concerns the gene PROS1 and melanoma.